Revenue ₹1,158 Cr (+9.7% YoY)
Healthcare
Tracked since Q3 FY26 - Q4 FY26
Akums Drugs & Pharmaceuticals Ltd
AKUMSDRUGSPHARMACEUTICAL
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Akums Drugs & Pharmaceuticals LtdAkums Drugs reported a strong Q4 FY26 with consolidated revenue of ₹1,158 crore (+9.7% YoY) and adjusted EBITDA of ₹1...
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.
Q4 FY26
15 May 2026
Revenue ₹1,158 Cr (+9.7% YoY)
Akums Drugs reported a strong Q4 FY26 with consolidated revenue of ₹1,158 crore (+9.7% YoY) and adjusted EBITDA of ₹152 crore (+61.6% YoY), driven by robust CDMO volum...
bullish
high
1 missed
Read full analysis →
Q3 FY26
26 Jan 2026
Revenue ₹1,160 Cr (+14.8% YoY)
Akums delivered a strong Q3 FY26 with operating revenue of ₹1,160 crore (+14.8% YoY) and EBITDA of ₹147 crore (+21% YoY), driven by 16% volume growth in CDMO and recov...
bullish
high
Scorecard starts after historical backfill
Read full analysis →